These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18280824)

  • 1. Growth hormone and fat distribution in SGA children.
    Daniels SR
    J Pediatr; 2008 Mar; 152(3):A3. PubMed ID: 18280824
    [No Abstract]   [Full Text] [Related]  

  • 2. Subclassification of small for gestational age children with persistent short stature: growth patterns and response to GH treatment.
    Ester W; Bannink E; van Dijk M; Willemsen R; van der Kaay D; de Ridder M; Hokken-Koelega A
    Horm Res; 2008; 69(2):89-98. PubMed ID: 18059089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone for small-for-gestational-age children: short and sweet?
    Silverstein JH; Shulman D
    J Pediatr; 2003 Feb; 142(2):91-2. PubMed ID: 12584522
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduced levels of GH during GnRH analogue treatment in pubertal short girls born small for gestational age (SGA).
    van der Kaay DC; Rose SR; van Dijk M; Noordam C; van Rheenen E; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):914-9. PubMed ID: 19178519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin sensitivity decreases in short children born small for gestational age treated with growth hormone.
    Bachmann S; Bechtold S; Bonfig W; Putzker S; Buckl M; Schwarz HP
    J Pediatr; 2009 Apr; 154(4):509-13. PubMed ID: 19038401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic implications of GH treatment in small for gestational age.
    Delemarre EM; Rotteveel J; Delemarre-van de Waal HA
    Eur J Endocrinol; 2007 Aug; 157 Suppl 1():S47-50. PubMed ID: 17785697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postnatal consequences of intrauterine development: pubertal development in children born small for gestational age].
    Woelfle J
    Klin Padiatr; 2008; 220(1):10-5. PubMed ID: 18172828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
    de Kort SW; Willemsen RH; van der Kaay DC; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):65-73. PubMed ID: 19094073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone treatment and fat redistribution in children born small for gestational age.
    De Schepper J; Thomas M; Beckers D; Craen M; Maes M; de Zegher F
    J Pediatr; 2008 Mar; 152(3):327-30. PubMed ID: 18280835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and growth hormone treatment in short stature children born small for gestational age.
    Labarta JI; Ruiz JA; Molina I; De Arriba A; Mayayo E; Longás AF
    Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone therapy for short children born small for gestational age.
    Chatelain P; Carrascosa A; Bona G; Ferrandez-Longas A; Sippell W
    Horm Res; 2007; 68(6):300-9. PubMed ID: 17823537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal use of growth hormone therapy for maximizing adult height in children born small for gestational age.
    Simon D; Léger J; Carel JC
    Best Pract Res Clin Endocrinol Metab; 2008 Jun; 22(3):525-37. PubMed ID: 18538291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma matrix metalloproteinase-9 levels and blood pressure in short children born small for gestational age and effects of growth hormone treatment.
    Willemsen RH; van Dijk M; de Kort SW; van Toorenenbergen AW; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):264-8. PubMed ID: 18284641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preterm growth restraint: a paradigm that unifies intrauterine growth retardation and preterm extrauterine growth retardation and has implications for the small-for-gestational-age indication in growth hormone therapy.
    Wit JM; Finken MJ; Rijken M; de Zegher F
    Pediatrics; 2006 Apr; 117(4):e793-5. PubMed ID: 16567394
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of growth hormone treatment in small for gestational age children.
    Poduval A; Saenger P
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):376-82. PubMed ID: 18594280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone-induced increases in skeletal muscle mass alleviates the associated insulin resistance in short children born small for gestational age, but not with growth hormone deficiency.
    Martin DD; Schweizer R; Schönau E; Binder G; Ranke MB
    Horm Res; 2009; 72(1):38-45. PubMed ID: 19571558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a consensus statement on management of short children born small for gestational age.
    Chernausek SD
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1275. PubMed ID: 12510979
    [No Abstract]   [Full Text] [Related]  

  • 18. Children born small for gestational age or with very low birth weight: clinical similarities and potential benefits of growth hormone therapy.
    Chatelain P
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():514-8. PubMed ID: 19550385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualization of growth hormone therapy.
    Johnston LB
    Best Pract Res Clin Endocrinol Metab; 2008 Jun; 22(3):517-24. PubMed ID: 18538290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term GH treatment on insulin sensitivity and glucose tolerance.
    Hokken-Koelega AC; Sas T; van Pareren Y
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1277-8. PubMed ID: 12510980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.